Conway Capital Management’s Exact Sciences EXAS Stock Holding History

Conway Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,250	Closed	-$297K	–	53
2022 Q1	$297K	Hold	4,250	–	–	0.19%	44
2021 Q4	$331K	Hold	4,250	–	–	0.19%	44
2021 Q3	$406K	Sell	4,250 -525	-11%	-$55.4K	0.27%	45
2021 Q2	$594K	Hold	4,775	–	–	0.41%	39
2021 Q1	$629K	Sell	4,775 -150	-3%	-$20.5K	0.47%	42
2020 Q4	$653K	Buy	+4,925	New	+$596K	0.48%	41

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Conway Capital Management's EXAS Position: Q2 2022 in Review

Conway Capital Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 4,250 shares — an estimated $297K sold.

Conway Capital Management first reported a position in EXAS in Q4 2020 and held it in 6 quarters. The position peaked at $653K in Q4 2020. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

Conway Capital Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
Conway Capital Management sold 4,250 Exact Sciences shares in Q2 2022, an estimated $297K.
Conway Capital Management first reported a position in Exact Sciences in Q4 2020 and held it in 6 quarters.
Conway Capital Management's Exact Sciences position peaked at $653K in Q4 2020.
501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Conway Capital Management's 13F filing for Q2 2022, filed 3 Dec 2024.